1,869
Views
0
CrossRef citations to date
0
Altmetric
Review

Overview and quality assessment of health economic evaluations for homeopathic therapy: an updated systematic review

, , , &
Pages 117-142 | Received 13 Jul 2023, Accepted 28 Sep 2023, Published online: 16 Oct 2023

References

  • Relton C, Cooper K, Viksveen P, et al. Prevalence of homeopathy use by the general population worldwide: a systematic review. Homeopathy. 2017;106(2):69–78. doi: 10.1016/j.homp.2017.03.002
  • Anheyer D, Koch AK, Anheyer M, et al. Integrative pediatrics survey: parents report high demand and willingness to self-pay for complementary and integrative medicine in German hospitals. Complement Ther Med. 2021;60:102757. doi: 10.1016/j.ctim.2021.102757
  • Adam D, Keller T, Mühlbacher A, et al. The value of treatment processes in Germany: a discrete choice experiment on patient preferences in complementary and conventional medicine. Patient. 2019;12(3):349–360. doi: 10.1007/s40271-018-0353-1
  • Colas A, Danno K, Tabar C, et al. Economic impact of homeopathic practice in general medicine in France. Health Econ Rev. 2015;5(1):55. doi: 10.1186/s13561-015-0055-5
  • Studer HP, Busato A. Comparison of Swiss basic health insurance costs of complementary and conventional medicine. Forsch Komplementmed. 2011;18(6):315–320. doi: 10.1159/000334797
  • Jain A. Does homeopathy reduce the cost of conventional drug prescribing? A study of comparative prescribing costs in general practice. Homeopathy. 2003;92(2):71–76. doi: 10.1016/s1475-4916-03-00004-3
  • May U, Bauer C. Apothekengestützte Selbstbehandlung bei leichteren Gesundheitsstörungen – Nutzen und Potenziale aus gesundheitsökonomischer Sicht. Gesundheitsökonomie & Qualitätsmanagement. 2017;22(S 01):S12–S22. doi: 10.1055/s-0042-120487
  • Securvita Krankenkasse. Securvita-Studie zur Homöopathie: Wirtschaftlich und wirksam. Securvital Das Magazin für Alternativen im Versicherungs- und Gesundheitswesen. 2021;20(4):6–11.
  • Ostermann JK, Reinhold T, Witt CM, et al. Can additional homeopathic treatment save costs? A Retrospective cost-analysis based on 44500 insured persons. PLoS One. 2015;10(7):e0134657. doi: 10.1371/journal.pone.0134657
  • Ostermann JK, Witt CM, Reinhold T, et al. A retrospective cost-analysis of additional homeopathic treatment in Germany: long-term economic outcomes. PLoS One. 2017;12(9):e0182897. doi: 10.1371/journal.pone.0182897
  • Baars EW, Zoen EB, Breitkreuz T, et al. The contribution of complementary and alternative medicine to reduce antibiotic use: a narrative review of health concepts, prevention, and treatment strategies. Evid Based Complement Alternat Med. 2019;2019:5365608. doi: 10.1155/2019/5365608
  • Grimaldi-Bensouda L, Bégaud B, Rossignol M, et al. Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in primary care: the EPI3 cohort study in France 2007-2008. PLoS One. 2014;9(3):e89990. doi: 10.1371/journal.pone.0089990
  • Grimaldi-Bensouda L, Abenhaim L, Massol J, et al. Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study. BMC Complement Altern Med. 2016;16:125. doi: 10.1186/s12906-016-1104-2
  • Palm J, Kishchuk VV, Ulied À, et al. Effectiveness of an add-on treatment with the homeopathic medication SilAtro-5-90 in recurrent tonsillitis: an international, pragmatic, randomized, controlled clinical trial. Complement Ther Clin Pract. 2017;28:181–191. doi: 10.1016/j.ctcp.2017.05.005
  • Witt CM. Health economic studies on complementary and integrative medicine. Forsch Komplementmed. 2011;18(1):6–9. doi: 10.1159/000324615
  • Ostermann T. On moving house, dachshunds, preferences, dictators, and health economics. J Complement Integr Med. 2022;28(12):909–910. DOI:10.1089/jicm.2022.29112.editorial.
  • Viksveen P, Dymitr Z, Simoens S. Economic evaluations of homeopathy: a review. Eur J Health Econ. 2014;15(2):157–174. doi: 10.1007/s10198-013-0462-7
  • Evers S, Goossens M, de Vet H, et al. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess Health Care. 2005;21(2):240–245. doi: 10.1017/S0266462305050324
  • Simoens S. Health economic assessment: a methodological primer. Int J Environ Res Public Health. 2009;6(12):2950–2966. doi: 10.3390/ijerph6122950
  • Ostermann T, Park AL, De Jaegere S, et al. Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only. Cost Eff Resour Alloc. 2021;19(1):60. doi: 10.1186/s12962-021-00313-4.
  • Nixon J, Khan KS, Kleijnen J. Summarising economic evaluations in systematic reviews: a new approach. BMJ. 2001;322(7302):1596–1598. doi: 10.1136/bmj.322.7302.1596.
  • Kass B, Icke K, Witt CM, et al. Effectiveness and cost-effectiveness of treatment with additional enrollment to a homeopathic integrated care contract in Germany. BMC Health Serv Res. 2020;20(1):872. doi: 10.1186/s12913-020-05706-4.
  • Colombo GL, Di Matteo S, Martinotti C, et al. The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis. Clinicoecon Outcomes Res. 2018;10:75–82. doi: 10.2147/ceor.S144300
  • Frei H. Homeopathic treatment of multimorbid patients: a prospective outcome study with polarity analysis. Homeopathy. 2015;104(1):57–65. doi: 10.1016/j.homp.2014.09.001
  • Roll S, Reinhold T, Pach D, et al. Comparative effectiveness of homoeopathic vs. conventional therapy in usual care of atopic eczema in children: long-term medical and economic outcomes. PLoS One. 2013;8(1):e54973. doi: 10.1371/journal.pone.0054973.
  • Basili A, Lagona F, Roberti di Sarsina P, et al. Allopathic versus homeopathic strategies and the recurrence of prescriptions: results from a pharmacoeconomic study in Italy. Evid Based Complement Alternat Med. 2011;2011:969343. doi: 10.1093/ecam/nep023
  • Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ. 2012;13(6):769–776. doi: 10.1007/s10198-011-0330-2
  • Thompson EA, Shaw A, Nichol J, et al. The feasibility of a pragmatic randomised controlled trial to compare usual care with usual care plus individualised homeopathy, in children requiring secondary care for asthma. Homeopathy. 2011;100(3):122–130. doi: 10.1016/j.homp.2011.05.001
  • Kneis KC, Gandjour A. Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults. Appl Health Econ Health Policy. 2009;7(3):181–191. doi: 10.1007/BF03256151
  • Pomposelli R, Piasere V, Andreoni C, et al. Observational study of homeopathic and conventional therapies in patients with diabetic polyneuropathy. Homeopathy. 2009;98(1):17–25. doi: 10.1016/j.homp.2008.11.006
  • Witt CM, Brinkhaus B, Pach D, et al. Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results. Dermatology. 2009;219(4):329–340. doi: 10.1159/000248854.
  • Sevar R. Audit of outcome in 455 consecutive patients treated with homeopathic medicines. Homeopathy. 2005;94(4):215–221. doi: 10.1016/j.homp.2005.07.002
  • Witt C, Keil T, Selim D, et al. Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med. 2005;13(2):79–86. doi: 10.1016/j.ctim.2005.03.005
  • Trichard M, Chaufferin G, Nicoloyannis N. Pharmacoeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children. Homeopathy. 2005;94(1):3–9. doi: 10.1016/j.homp.2004.11.021
  • Trichard M, Chaufferin G, Dubreuil C, et al. Effectiveness, quality of life, and cost of caring for children in France with recurrent acute rhinopharyngitis managed by homeopathic or non-homeopathic general practitioners. Dis Manage Health Outcomes. 2004;12(6):419–427. doi: 10.2165/00115677-200412060-00009
  • Slade K, Chohan BP, Barker PJ. Evaluation of a GP practice based homeopathy service. Homeopathy. 2004;93(2):67–70. doi: 10.1016/j.homp.2004.02.005
  • Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy. 2004;93(1):3–11. doi: 10.1016/j.homp.2003.11.010
  • Paterson C, Ewings P, Brazier JE, et al. Treating dyspepsia with acupuncture and homeopathy: reflections on a pilot study by researchers, practitioners and participants. Complement Ther Med. 2003;11(2):78–84. doi: 10.1016/s0965-2299(03)00056-6
  • Frei H, Thurneysen A. Homeopathy in acute otitis media in children: treatment effect or spontaneous resolution? Br Homeopath J. 2001;90(4):180–182. doi: 10.1054/homp.1999.0505
  • Bachinger A, Rappenhöner B, Rychlik R. Zur sozioökonomischen Effizenz einer Zeel-comp.-Therapie im Vergleich zu Hyaluronsaeure bei Patienten mit Gonathrose. [Socioeconomical efficiency of a Zeel-comp.-therapy in comparison to hyaluronic acid in patients with gonarthrosis]. Z Orthop. 1996;134(4):Oa20–1.
  • Feldhaus HW. Cost-effectiveness of homoeopathic treatment in a dental practice. Br Homeopath J. 1993;82:22–28. doi: 10.1016/S0007-0785(05)80950-0
  • Libessart Y. Une alternative homéopathique en pédiatrie, le purpura rhumatoïde de Schönlein-Henoch. La Revue d’Homéopathie. 2012;3(4):140–142. doi: 10.1016/j.revhom.2012.10.013
  • Fibert P, Peasgood T, Relton C. Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology. Eur J Pediatr. 2019;178(7):983–993. doi: 10.1007/s00431-019-03374-z
  • Singh P, Mukherjee K. Cost-benefit analysis and assessment of quality of care in patients with hemophilia undergoing treatment at national rural health mission in Maharashtra, India. Value Health Reg Issues. 2017;12:101–106. doi: 10.1016/j.vhri.2016.11.003
  • Herman PM, Poindexter BL, Witt CM, et al. Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations. BMJ Open. 2012;2(5). doi: 10.1136/bmjopen-2012-001046
  • Li H, Jin X, Herman PM, et al. Using economic evaluations to support acupuncture reimbursement decisions: current evidence and gaps. BMJ. 2022;376:e067477. doi: 10.1136/bmj-2021-067477
  • Xiong X, Jiang X, Lv G, et al. Evidence of Chinese herbal medicine use from an economic perspective: a systematic review of pharmacoeconomics studies over two decades. Front Pharmacol. 2022;13:765226. doi: 10.3389/fphar.2022.765226
  • Yan J, Bao S, Liu L, et al. Reporting quality of economic evaluations of the negotiated traditional Chinese medicines in national reimbursement drug list of China: a systematic review. Integr Med Res. 2023;12(1):100915. doi: 10.1016/j.imr.2022.100915
  • von Ammon K, Sauter U, Frei H, et al. Classical homeopathy helps hyperactive children –a 10-year follow-up of homeopathic and integrated medical treatment in children suffering from attention deficit disorder with and without hyperactivity. Eur J Integr Med. 2012;4:73–74. doi: 10.1016/j.eujim.2012.07.645
  • Thompson E, Griffin T, Hamilton W, et al. Economic evaluation of the Bristol homeopathic hospital: final results of the BISCUIT feasibility study. Homeopathy. 2014;103(1). doi: 10.1016/j.homp.2013.10.037
  • Bradley SH, DeVito NJ, Lloyd KE, et al. Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps. J R Soc Med. 2020;113(11):433–443. doi: 10.1177/0141076820956799
  • Ostermann T, Krummenauer F, Heusser P, et al. Health economic evaluation in complementary medicine: development within the last decades concerning local origin and quality. Complement Ther Med. 2011;19(6):289–302. doi: 10.1016/j.ctim.2011.09.002
  • Ostermann T, Baars E, McDaid D. Time to stand up and be counted: the need for an economic case for investment. Complement Ther Med. 2016;27:137–138. doi: 10.1016/j.ctim.2016.06.008